U.S. federal trademark · Serial No. 78536178 · Reg. No. 3169721
Pharmaceutical preparation with antiviral and/or antimicrobial properties for herpes related microbial infections, namely, herpes simplex virus, varicella zoster virus (herpes zoster) (shingles), cytomegalovirus, and cold sores and for use in the treatment of herpetic keratitis, conjunctivitis, HIV retinopathy, viral influenza (flu), herpes simplex virus 1, herpes simplex virus 2, esptein barr, papilloma virus, viral parainfluenza, adenovirus, viral encephalits, viral menigitus, arbovirus, arenavirus, picornavirus, coronavirus, syntialvirus, viral infections, common colds caused by viruses, human immunedeficiency virus (HIV), geniculate zoster, chicken pox, roseola infantum, organ transplant rejection, pneumonia, infectious mononucleosis, uveitis, retinitis, human cervical carcinoma, vaginal carcinoma, vulvovaginitis, human herpes IV, and Kaposi's sarcoma; and for cold sore treatment
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.